Details of the Drug-Related molecule(s) Interaction Atlas

US8877733, 28 Drug Info

CHEMBL3686494; BDBM139221; US8877733, 28

Cross-matching ID

PubChem CID

91669039

TTD Drug ID

DMLY3RE

General Information of Drug (ID: DMLY3RE)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Hepatitis C virus Core protein messenger RNA (HCV Core mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US10087167, Compound 4001	DMAP1DN	N. A.	N. A.	Patented	[2]
US10087167, Compound 3002	DMM6WAB	N. A.	N. A.	Patented	[2]
US10150740, Example 4	DMKM93Q	N. A.	N. A.	Patented	[3]
US10150740, Example 9	DM1VPLU	N. A.	N. A.	Patented	[3]
US8877733, 27	DMDN8P1	N. A.	N. A.	Patented	[1]
US10087167, Compound 3003	DMITOY6	N. A.	N. A.	Patented	[2]
US10150740, Example 1	DME2AZG	N. A.	N. A.	Patented	[3]
ISIS 11155	DMB31GR	Discovery agent	N.A.	Investigative	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis C virus Core protein messenger RNA (HCV Core mRNA)	TTQFZWR	POLG_HCV1	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	1-substituted pyrimidine N-nucleoside analogs for antiviral treatment. US8877733.
2	Benzofurans substituted with secondary benzamide as HCV inhibitors. US10087167.
3	6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection. US10150740.
4	US patent application no. 6,391,542, Compositions and methods for treatment of Hepatitis C virus-associated diseases.